MedPath

Are suspected auditory processing disorders in children between 8 and 12 years of age related to auditory and/or visual attention?

Completed
Conditions
(suspected) auditory processing disorders / listening problems
10010118
Registration Number
NL-OMON40489
Lead Sponsor
Hanzehogeschool Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
46
Inclusion Criteria

Age: 8;0 to 12;0 years
Monolingual: Dutch as mother language
Normal peripheral hearing (hearing loss of up to 20 dBHL on frequencies 500, 1000, 2000 and 4000 Hz)
Normal vision (Visual acuity > 0.80 (80%) without or with optimal correction (glasses))
Non verbal intelligence IQ*80
Language comprehension and production Q*80
Absence of additional and/or diagnosed developmental disorder, such as autism, ADHD, dyslexie, SLI etc. ;Children with suspected auditory processing disorder:
Presence of listeningproblems (clinical presentation) which would lead to a referral for a APD research. Suspicions on the basis of the experience of the parent(s) and/or the teacher.;Control group:
Typical developing children without listening problems.

Exclusion Criteria

Bi- or multilingualism
Hearing problems
Serious visual problems (visually impaired or blind)
Cognitive problems (non-verbal IQ<80)
Language comprehension or production problems (Q<80)
Severe speech production problems
Presence of a diagnosed developmental disorder (SLI, ASS-diagnosis, ADHD, determined syndrome)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is the difference between children with suspected ADP and<br /><br>the control group on the selected visual and auditory attention tasks. The<br /><br>primary outcome measure is the% correct score and response time on auditory and<br /><br>visual attention tasks.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable. </p><br>
© Copyright 2025. All Rights Reserved by MedPath